No trials match your search ""

• Magnetic Resonance Imaging of Breast Cancer

  Stanford is currently accepting patients for this trial.

• A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

  Stanford is currently accepting patients for this trial.

• Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample

  Stanford is currently accepting patients for this trial.

• Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema

  Stanford is currently accepting patients for this trial.

• Phase II Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma

  Stanford is currently accepting patients for this trial.

• Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma

  Stanford is currently accepting patients for this trial.

• Pivotal Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

  Stanford is currently accepting patients for this trial.

• G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

  Stanford is currently accepting patients for this trial.

• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

  Stanford is currently accepting patients for this trial.

• Molecular and Cellular Analysis of Breast Cancer

  Stanford is currently accepting patients for this trial.

• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

  Stanford is currently accepting patients for this trial.

• Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

  Stanford is currently accepting patients for this trial.

• Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

  Stanford is currently accepting patients for this trial.

• Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

  Stanford is currently accepting patients for this trial.

• A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

  Stanford is currently accepting patients for this trial.

• Phase II Talazoparib in BRCA1 +BRCA2 Wild-Type &Triple-Neg /HER2-Negative Breast Cancer /SolidTumors

  Stanford is currently accepting patients for this trial.

• Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Previous
• 1
• 2
• Next

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

• International Lymphatic Disease and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

• Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

  Stanford is currently accepting patients for this trial.

• A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma

  Stanford is currently accepting patients for this trial.

• A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

  Stanford is currently accepting patients for this trial.

• Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• Pre-Operative Cemiplimab Administered Intralesionally for Patients With Recurrent Cutaneous Squamous Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

  Stanford is currently accepting patients for this trial.

• Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer, STAMP Study

  Stanford is currently accepting patients for this trial.

• Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)

  Stanford is currently accepting patients for this trial.

• CemiplimAb Survivorship Epidemiology

  Stanford is currently accepting patients for this trial.

• Pembrolizumab Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

  Stanford is currently accepting patients for this trial.

• Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

  Stanford is currently accepting patients for this trial.

• Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

  Stanford is currently accepting patients for this trial.

• A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma

  Stanford is currently accepting patients for this trial.

• A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

  Stanford is currently accepting patients for this trial.

• Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds

  Stanford is currently accepting patients for this trial.

• Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation

  Stanford is currently accepting patients for this trial.

• Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

  Stanford is currently accepting patients for this trial.

• Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

  Stanford is currently accepting patients for this trial.

• Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

  Stanford is currently accepting patients for this trial.

• ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer

  Stanford is currently accepting patients for this trial.

• Selinexor in Advanced Liposarcoma

  Stanford is currently accepting patients for this trial.

No trials match your search ""